Redeye: Bredband2 - Margin focus ahead
Redeye makes minor forecast adjustments following Bredband2’s Q3 2022 report, where sales and EBIT came in somewhat below expectations, while the net customer intake continues to be in positive territory. Accordingly, the forecast adjustments combined with an increased WACC give rise to a new fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.